Lutetium yog kev kho hluav taws xob uas siv cov molecule los txuas nws tus kheej mus rau PSMA receptors nyob rau ntawm cov qog nqaij hlav cancer. Lutetium-177 tso tawm beta hluav taws xob uas ua rau cov qog nqaij hlav cancer zoo thiab, dhau sijhawm, ua rau lawv puas tsuaj.
Kev kho lutetium yog dab tsi?
Lutetium PSMA kev kho yog dab tsi? Lutetium-177 PSMA (Prostate specific membrane antigen) kev kho mob yog ib hom kev kho mob radionuclide uas aims los rhuav tshem cov qog nqaij hlav prostate uas tau kis mus rau qhov chaw ntawm lub cev, suav nrog cov qog nqaij hlav thiab pob txha.
Lutetium-177 muab li cas?
Thaum muab tso rau hauv txoj hlab ntshav Lutetium-177 PSMA ligand yuav mus rau cov chaw uas muaj PSMA tam sim no thiab tawm hluav taws xob uas yuav rhuav tshem cov qog nqaij hlav; Txoj kev kho mob yog tsom rau cov qog nqaij hlav uas muaj hluav taws xob tsawg heev rau lwm qhov hauv lub cev.
Lutetium-177 nqi npaum li cas?
Tus nqi nruab nrab ntawm Lutetium-177 kho yog $ 10, 000 ib chav kawm.
hom hluav taws xob twg lutetium emit?
Peptide Receptor Radiotherapy
Lu ua haujlwm los ntawm emitting beta hluav taws xob tom qab khi rau SSTR ntawm cov qog. Tsis ntev los no FDA tau pom zoo, nws tau qhia nyob rau hauv qib siab G1 thiab G2 GI thiab PNETs uas qhia txog somatostatin receptors.